USFDA concludes pre-approval inspection at Torrent Pharmaceuticals’ Gujarat facility

12 Dec 2023 Evaluate

The United States Food and Drug Administration (USFDA) has concluded Pre-Approval Inspection (PAI) at Torrent Pharmaceuticals’ Oral-Oncology manufacturing facility at Bileshwarpura, Gujarat. The Inspection was conducted from December 05, 2023 to December 11, 2023. 

At the end of the inspection, the Company was issued a Form 483 with 5 procedural observations. There was no observation related to data integrity reported. 

Torrent Pharmaceuticals is flagship company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.

Torrent Pharma Share Price

3797.70 -15.15 (-0.40%)
29-Dec-2025 15:14 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1715.40
Dr. Reddys Lab 1267.95
Cipla 1495.10
Zydus Lifesciences 905.10
Lupin 2082.20
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×